Total planned funding: $515,446,399
Clear active filters
Own Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Ethiopia | $52,922,254 |
| Uganda | $43,501,504 |
| Tanzania | $42,466,285 |
| South Africa | $40,439,174 |
| Kenya | $38,384,710 |
| Mozambique | $36,916,038 |
| Zambia | $36,257,786 |
| Nigeria | $34,967,697 |
| Rwanda | $24,453,077 |
| Côte d'Ivoire | $23,483,086 |
| Botswana | $22,828,711 |
| Vietnam | $18,038,285 |
| Namibia | $16,381,792 |
| Haiti | $12,930,000 |
| Malawi | $7,891,719 |
| Zimbabwe | $7,252,404 |
| Caribbean Region | $6,952,463 |
| Democratic Republic of the Congo | $5,598,302 |
| India | $5,435,154 |
| Guyana | $5,296,620 |
| Cambodia | $4,871,081 |
| Eswatini | $4,321,675 |
| Lesotho | $3,786,254 |
| Angola | $3,678,360 |
| Thailand | $3,670,731 |
| Dominican Republic | $2,925,135 |
| South Sudan | $2,816,782 |
| Russia | $1,793,432 |
| Ghana | $1,650,700 |
| China | $1,614,000 |
| Ukraine | $985,188 |
| Indonesia | $936,000 |
Organizational Types
| Own Agency | $515,446,399 |
Program Areas
| Management and Operations | $300,391,822 |
| Governance and Systems | $89,750,313 |
| Prevention | $56,703,365 |
| Care | $37,132,418 |
| Treatment | $24,275,922 |
| Testing | $7,192,559 |
Budget Codes
| HVMS: Management and Operations | $300,391,822 |
| HVSI: Strategic Information | $47,320,949 |
| HLAB: Laboratory Infrastructure | $25,553,397 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $21,924,493 |
| HTXS: Treatment: Adult Treatment | $21,497,193 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $21,471,620 |
| OHSS: Health Systems Strengthening | $16,875,967 |
| HBHC: Care: Adult Care and Support | $14,773,014 |
| HKID: Care: Orphans and Vulnerable Children | $11,330,269 |
| HVTB: Care: TB/HIV | $11,029,135 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,578,579 |
| HVCT: Testing: HIV Testing and Counseling | $7,192,559 |
| HTXD: Treatment: ARV Drugs | $2,778,729 |
| HMBL: Biomedical Prevention: Blood Safety | $1,769,792 |
| HMIN: Biomedical Prevention: Injection Safety | $958,881 |